АНАЛІЗ ПРОЛІФЕРАТИВНОЇ АКТИВНОСТІ ТА РІВНІВ ЕКСПРЕСІЇ ДІАГНОСТИЧНИХ ЦИТОКЕРАТИНІВ В ЕПІТЕЛІАЛЬНИХ ПУХЛИНАХ ЯЄЧНИКІВ З РІЗНИМ ПОТЕНЦІАЛОМ ЗЛОЯКІСНОСТІ

QR Code

АНАЛІЗ ПРОЛІФЕРАТИВНОЇ АКТИВНОСТІ ТА РІВНІВ ЕКСПРЕСІЇ ДІАГНОСТИЧНИХ ЦИТОКЕРАТИНІВ В ЕПІТЕЛІАЛЬНИХ ПУХЛИНАХ ЯЄЧНИКІВ З РІЗНИМ ПОТЕНЦІАЛОМ ЗЛОЯКІСНОСТІ

У роботі був проведений ретроспективний аналіз матеріалу 70 жінок віком від 19 до 76 років (середній вік 46,95±14,84; медіана 46) з діагнозом епітеліальної пухлини яєчників (ЕПЯ). Метою дослідження стало порівняння рівнів експресії маркерів проміжних філаментів цитокератинів (СК7, СК20), онкопротеїн...

Full description

Saved in:

Bibliographic Details
Main Authors:	О. А. Савченко, І. С. Шпонька, О. В. Пославська, П. В. Савченко
Format:	Article
Language:	English
Published:	State Institution "Dnipro State Medical University" 2017-12-01
Series:	Морфологія
Subjects:	епітеліальні пухлини cyclin 7 cyclin 20 p53 Ki-67
Online Access:	http://morphology.dma.dp.ua/article/view/129258
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Імуногістохімічні особливості епітеліальних новоутворень яєчників різного потенціалу злоякісності.
by: O. A. Savchenko
Published: (2019-09-01)

Cyclin F Expression in Clear Cell Renal Cell Carcinoma and Its Effect on Biological Behavior of Renal Carcinoma Cell Lines
by: Min SU, et al.
Published: (2025-06-01)

Study of cytostatic and cytotoxic characteristics of modified peptide CDK4/6 inhibitors – functional analogs of p16INK4a (90-97)
by: V. K. Bozhenko, et al.
Published: (2021-01-01)

The Difference in the Cyclin D1 Expression in Advanced Stage Nasopharyngeal Cancer based on Treatment Response: A Retrospective Cohort Study
by: Cosphiadi Irawan, et al.
Published: (2020-08-01)

The Difference in the Cyclin D1 Expression in Advanced Stage Nasopharyngeal Cancer based on Treatment Response: A Retrospective Cohort Study
by: Cosphiadi Irawan, et al.
Published: (2020-08-01)

Prognostic Value of Cyclin D1 Overexpression in Invasive Breast Carcinoma
by: Funda Taşlı, et al.
Published: (2025-04-01)

Functional Analysis of the Cyclin E Gene in the Reproductive Development of Rainbow Trout (<i>Oncorhynchus mykiss</i>)
by: Enhui Liu, et al.
Published: (2025-07-01)

Advancements in Dalpiciclib for the Treatment of Breast Cancer Patients: A Review
by: Chen Z, et al.
Published: (2025-06-01)

Cyclin D1 regulates osteoarthritis chondrocyte apoptosis via WNT3/β-catenin signalling
by: Yi-Yue Chen, et al.
Published: (2019-12-01)

Assessment of Alterations in the Expression of P53 and Cyclin-D Genes in COVID-19 Patients Before and After Remdesivir Treatment
by: Somayeh Arabzadeh, et al.
Published: (2025-01-01)

دراسة بعض الماركرات في النساء العراقيات المريضات بسرطان الثدي
by: Abeer M. Hussain, et al.
Published: (2021-12-01)

The impact of cyclin D1 on endometrial hyperplasia and endometrioid endometrial carcinoma
by: Sudha M, et al.
Published: (2025-06-01)

Phloretin–Chitosan Nanoparticles and Tamoxifen: Synergistic Modulation of BRCA Genes and Enhanced Sensitization in Breast Cancer
by: Abeer A. Ageeli, et al.
Published: (2025-04-01)

Predictive immunohistochemical indicators of regional metastasis of laryngeal squamous cell carcinoma
by: Kovtunenko A.V., et al.
Published: (2014-12-01)

Hormone therapy for premenopausal women with metastatic breast cancer: combinations with cyclin-dependent kinase inhibitors
by: E. V. Artamonova, et al.
Published: (2019-09-01)

Effectiveness of cyclin-dependent kinase 4 and 6 inhibitors for the treatment of hormonesensitive HER2-negative metastatic breast cancer in first-line therapy: A systematic literature review
by: N. A. Avxentyev, et al.
Published: (2024-05-01)

Decidual natural killer cells and trophoblast cells: cellular, humoral and molecular mechanisms of interaction
by: P. V. Grebenkina, et al.
Published: (2022-12-01)

ROLE OF CYCLIN D1 IN THE MECHANISMS OF TAMOXIFEN RESISTANCE
by: D. B. Erdyneeva, et al.
Published: (2020-09-01)

HORMONE-POSITIVE HER2-NEGATIVE METASTATIC BREAST CANCER: DECISION MAKING IN REAL CLINICAL PRACTICE
by: L. Yu. Vladimirova, et al.
Published: (2020-06-01)

Exploring the Therapeutic Potential of Antiaris africana: Targeting Cyclin-Dependent Kinases 8 and 13 for Cancer Treatment through Molecular Docking Studies
by: Mutiu A. Alabi, et al.
Published: (2025-06-01)

Evolution of systemic treatment for hormone-sensitive breast cancer: from sequential use of single agents to the upfront administration of drug combinations
by: E. N. Imyanitov
Published: (2016-09-01)

Estimation of the state of proliferative activity and expression of the oncomarker p53 in samples of actinic keratosis.
by: V. S. Hlushok, et al.
Published: (2017-09-01)

Efficacy of cyclin-dependent kinases 4 and 6 inhibitors in the treatment of HR +/HER2 − advanced breast cancer: a meta-analysis
by: Isah Adamu Danbala, et al.
Published: (2025-06-01)

Generation of a human induced pluripotent stem cell reporter line to investigate cell division and proliferation
by: Alessia Costa, et al.
Published: (2025-09-01)

A real-world study of palbociclib plus endocrine therapy with or without a short course chemotherapy in the first-line treatment of HR-positive HER2-negative metastatic breast cancer
by: Xiangjun Li, et al.
Published: (2025-07-01)

Cyclin D2 – a potential biomarker in uterine corpus endometrial carcinoma through methylation chip and bioinformatic analysis
by: Lizhen Wang, et al.
Published: (2025-07-01)

Treatment of luminal HER2-negative breast cancer: opinion of experts
by: E. V. Artemeva, et al.
Published: (2024-06-01)

miR-21-5p inhibitor enhances the radiosensitivity of human cervical cancer cells via blocking CPEB3-mediated CDK1/cyclin B pathway
by: Liang Jiao, et al.
Published: (2025-09-01)

Metabolic aspects of clinical remission prediction from baseline blood gene expression in patients with rheumatoid arthritis treated with methotrexate
by: E. V. Chetina, et al.
Published: (2019-05-01)

Evaluating the Role of Genetic Markers in Predicting Oral Leukoplakia Malignancy Transformation
by: Ahtesham Ahmad Qurishi, et al.
Published: (2025-06-01)

Конструктивні рішення для попередження розвитку вторинної катаракти після імплантації інтраокулярних лінз
by: Alexander Polischuk, et al.
Published: (2020-03-01)

Mantle Zone Cell Lymphomas. New Opportunities for Diagnosis and Treatment (Epidemiological Research)
by: E. I. Kankumasheva, et al.
Published: (2020-01-01)

PREVENTION AND MONITORING OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER
by: N. A. Kozyavin, et al.
Published: (2018-08-01)

THE USE OF PALBOCKLIB, A CYCLINE-DEPENDENT KINASE 4/6 INHIBITOR, IN THE TREATMENT OF METASTATIC BREAST CANCER. A COST-CONSEQUENCE ANALYSIS
by: S. L. Pavlinsky, et al.
Published: (2017-09-01)

Serum Analysis of Adeno-associated Virus 2 and Some Cell-cycle Regulatory Protein Levels in a Group of Iraqi Patients with Hepatocellular Carcinoma
by: Jasim Mohammed Muhsin, et al.
Published: (2025-04-01)

Deletion of cyclin dependent kinase inhibitor 2a gene as a marker of oropharyngeal carcinomas non-associated with human papillomavirus and its prognostic value
by: I.S. Shponka, et al.
Published: (2024-06-01)

The impact of ROR1, BMI-1 expression and <i>PIK3CA</i> mutation on the prognosis of luminal breast cancer
by: S. V. Vtorushin, et al.
Published: (2025-05-01)

Tanshinone IIA alleviates liver fibrosis by suppressing hepatic stellate cell proliferation via ERK/cyclin D1/p-Smad3L signaling axis
by: Wenjing Liao, et al.
Published: (2025-05-01)

РАДІОХІРУРГІЧНИЙ МЕТОД ЛІКУВАННЯ ЕПІТЕЛІАЛЬНИХ ПУХЛИН ШКІРИ
by: О. О. Оshivalova, et al.
Published: (2017-12-01)

Features of expression of immunohistochemical markers in local and generalized clear cell kidney cancer
by: E. M. Frantsiyants, et al.
Published: (2020-03-01)